Trump’s Economic Nationalism Escalates, Pressures India and BRICS

President Donald Trump's aggressive trade policies have taken direct aim at the BRICS bloc, with a blanket 10% tariff on member nations and potential 200% levies on pharmaceutical imports. These measures threaten to ignite an India-US trade war, particularly targeting India's crucial pharmaceutical exports. The tariffs risk disrupting global supply chains and applying significant pressure to BRICS initiatives aimed at reducing dollar dependence in international trade.

The BRICS coalition, representing over 32% of global GDP and 40% of the world's population, has been actively pursuing de-dollarization strategies that challenge US economic dominance. US imports from BRICS nations totaled $886 billion in 2024 - the new tariffs WOULD impose approximately $88 billion in additional duties, potentially stalling the bloc's economic momentum and currency diversification efforts.